{"id":47292,"date":"2022-08-15T17:02:04","date_gmt":"2022-08-15T15:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/"},"modified":"2022-08-15T17:02:04","modified_gmt":"2022-08-15T15:02:04","slug":"cerrozone-receives-fda-510k-class-ii-clearance","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/","title":{"rendered":"CerroZone\u2122 Receives FDA 510(k) Class II Clearance"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–CerroZone\u2122 LLC\u2019s new mobile air purification device has earned 510(k) Class II clearance from the U.S. Food and Drug Administration as a recirculating air cleaner for eliminating airborne viruses and bacteria. The FDA approval was contingent on extensive testing at accredited independent third-party facilities.\n<\/p>\n

<\/a><\/p>\n

\nThe CerroZone mobile unit is designed to purify air in buildings such as schools, retail environments, offices, and other indoor spaces. CerroZone\u2019s indoor system achieved a 99.998 percent reduction of live COVID-19 Delta Variant in a single pass of approximately 1.2 seconds, according to independent testing at MRI Global in Kansas City.\n<\/p>\n

\nUnlike other solutions, the CerroZone product features patented ozone technology. \u201cThis is the first technology to truly harness the disinfecting power of ozone in a way that is safe for consumers and the environment,\u201d said Michael Duggan, President of St. Louis, Mo.-based CerroZone. \u201cIt will fundamentally change the industry standard for air purification.\u201d\n<\/p>\n

\nCerroZone previously announced it had achieved Intertek\u2019s Zero Ozone Certification. Intertek considers emissions of .005 ppm or less to be negligible per UL 2998, the North American industry standard for ozone testing. The CerroZone unit recorded at only .001 ppm.\n<\/p>\n

\nAmong its benefits to the market, the CerroZone\u2122 platform only requires annual preventive maintenance, unlike filtration-based systems that need quarterly replacement of filters and other components.\n<\/p>\n

\n\u201cToday’s news further validates the exceptional quality of our system,\u201d said Marlon Robinson, Director of Operations for CerroZone. \u201cWe knew the effectiveness of the CerroZone unit based on our prior testing, including on live COVID-19. To show similar effectiveness on a different strain reinforces that CerroZone is positioned to aid the public in the fight against emerging and future variants.\u201d\n<\/p>\n

\nRobinson added, \u201cWe are now ready to commercialize this amazing technology. We have been methodical in our approach, with successful field trials consistently demonstrating our product\u2019s performance. We look forward to providing the market with an effective, proven solution including an attractive preventive maintenance schedule.\u201d\n<\/p>\n

\nThe patented CerroZone system was developed in conjunction with Micron Pure\u2122, a Hecto Group\u2122 company.\n<\/p>\n

\nCerroZone is part of the Marmon Plumbing & Refrigeration group of Chicago-based Marmon Holdings, Inc. Marmon Holdings, a Berkshire Hathaway company, is a global industrial organization comprising 11 diverse business groups and more than 100 autonomous manufacturing and service businesses.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nsales@cerrozone.com<\/a> or visit www.CerroZone.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–CerroZone\u2122 LLC\u2019s new mobile air purification device has earned 510(k) Class II clearance from the U.S. Food and Drug Administration as a recirculating air cleaner for eliminating airborne viruses and bacteria. The FDA approval was contingent on extensive testing at accredited independent third-party facilities. The CerroZone mobile unit is designed to purify air in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47292","6":"format-standard","7":"category-industry"},"yoast_head":"\nCerroZone\u2122 Receives FDA 510(k) Class II Clearance - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CerroZone\u2122 Receives FDA 510(k) Class II Clearance - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–CerroZone\u2122 LLC\u2019s new mobile air purification device has earned 510(k) Class II clearance from the U.S. Food and Drug Administration as a recirculating air cleaner for eliminating airborne viruses and bacteria. The FDA approval was contingent on extensive testing at accredited independent third-party facilities. The CerroZone mobile unit is designed to purify air in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-15T15:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220815005128\/en\/827993\/21\/CerroZone_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CerroZone\u2122 Receives FDA 510(k) Class II Clearance\",\"datePublished\":\"2022-08-15T15:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005128\\\/en\\\/827993\\\/21\\\/CerroZone_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/\",\"name\":\"CerroZone\u2122 Receives FDA 510(k) Class II Clearance - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005128\\\/en\\\/827993\\\/21\\\/CerroZone_Logo.jpg\",\"datePublished\":\"2022-08-15T15:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005128\\\/en\\\/827993\\\/21\\\/CerroZone_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005128\\\/en\\\/827993\\\/21\\\/CerroZone_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerrozone-receives-fda-510k-class-ii-clearance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CerroZone\u2122 Receives FDA 510(k) Class II Clearance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CerroZone\u2122 Receives FDA 510(k) Class II Clearance - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/","og_locale":"en_US","og_type":"article","og_title":"CerroZone\u2122 Receives FDA 510(k) Class II Clearance - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–CerroZone\u2122 LLC\u2019s new mobile air purification device has earned 510(k) Class II clearance from the U.S. Food and Drug Administration as a recirculating air cleaner for eliminating airborne viruses and bacteria. The FDA approval was contingent on extensive testing at accredited independent third-party facilities. The CerroZone mobile unit is designed to purify air in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-15T15:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220815005128\/en\/827993\/21\/CerroZone_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CerroZone\u2122 Receives FDA 510(k) Class II Clearance","datePublished":"2022-08-15T15:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/"},"wordCount":394,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220815005128\/en\/827993\/21\/CerroZone_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/","url":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/","name":"CerroZone\u2122 Receives FDA 510(k) Class II Clearance - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220815005128\/en\/827993\/21\/CerroZone_Logo.jpg","datePublished":"2022-08-15T15:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220815005128\/en\/827993\/21\/CerroZone_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220815005128\/en\/827993\/21\/CerroZone_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cerrozone-receives-fda-510k-class-ii-clearance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CerroZone\u2122 Receives FDA 510(k) Class II Clearance"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47292"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47292\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}